Can Stereotactic Ablative Radiotherapy (SABR) Improve Patient Selection for Lung Cancer Surgery and Reduce Perioperative Mortality?

被引：0
|
作者：
Serrano, Nicholas [1 ]
Adams, Bret [2 ]
Szentpetery, Szabolcs [3 ]
Rogers, C. Leland [4 ]
Chang, Michael [4 ]
Moghanaki, Drew [4 ]
机构：
[1] Virginia Commonwealth Univ, Radiat Oncol, Richmond, VA USA
[2] Univ Miami, Radiat Oncol, Miami, FL USA
[3] Hunter Holmes Mcguire Vet Affairs Med Ctr, Thorac Surg, Richmond, VA USA
[4] Hunter Holmes Mcguire Vet Affairs Med Ctr, Radiat Oncol, Richmond, VA USA
来源：
JOURNAL OF THORACIC ONCOLOGY | 2015年 / 10卷 / 09期
关键词：
SABR; NSCLC; stereotactic;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
MINI18.13
引用
收藏
页码：S329 / S329
页数：1
相关论文
共 50 条
  • [41] Radiomics for Early Detection of Recurrence in Patients Treated with Lung Stereotactic Ablative Radiotherapy (SABR)
    Kunkyab, T.
    Mou, B.
    Jirasek, A.
    Haston, C.
    Andrews, J.
    Thomas, S.
    Hyde, D.
    MEDICAL PHYSICS, 2020, 47 (06) : E436 - E436
  • [42] Imaging follow-up after stereotactic ablative radiotherapy (SABR) for lung tumors
    Lo, Simon S.
    Teh, Bin S.
    Mayr, Nina A.
    Chiang, Stephen B.
    Huang, Zhibin
    Yao, Min
    Machtay, Mitchell
    JOURNAL OF RADIATION ONCOLOGY, 2012, 1 (01) : 11 - 16
  • [43] Can Clinical Variables be used to Provide Better Follow up in Stereotactic Ablative Radiotherapy (SABR) Treated Lung Cancers?
    Hatton, N.
    Saha, A.
    Beasley, M.
    Franks, K.
    Clarke, K.
    Jain, P.
    Teo, M.
    Murray, P.
    Lilley, J.
    Dickinson, P.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S142 - S142
  • [44] PEARL: Pathologic Effect of NeoAdjuvant Stereotactic Ablative Body Radiotherapy (SABR) in Operable Early Stage Lung Cancer
    Van Meerbeeck, Jan P.
    Vandecasteele, Katrien
    Tournoy, Kurt
    Vermaelen, Karim Y.
    De Ryck, Frederic
    Surmont, Veerle F.
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S680 - S680
  • [45] Audit of radiotherapy plan quality for stereotactic ablative radiotherapy (SABR) for stage 1 non-small cell lung cancer
    Pascoe, A. C.
    Foweraker, K.
    Esler, C.
    Morgan, S.
    Wallace, A.
    Launders, D.
    Harron, E.
    CLINICAL ONCOLOGY, 2016, 28 : S4 - S4
  • [46] Outcome of stereotactic ablative radiotherapy (SABR) in early stage non-small cell lung cancer (NSCLC)
    Islam, Mohammad
    Cyriac, Abby
    Durga, Tarun
    Sarkodie, Thomas
    Begum, Gulshad
    Evans, Joanne
    Palvai, Sreekanth
    Tun, Khin
    LUNG CANCER, 2023, 178 : S55 - S55
  • [47] Stereotactic ablative body radiotherapy (SABR) for early lung cancer: implementation and outcomes at University College London Hospital
    Osborn, K.
    Ahmed, M.
    Allington, L.
    Haji, N.
    Mendes, R.
    LUNG CANCER, 2014, 83 : S61 - S61
  • [48] Quality of Life and Symptoms in Patients Undergoing Stereotactic Ablative Body Radiotherapy (SABR) for Early Stage Lung Cancer
    Gray, C.
    Wingate, E.
    Ghafoor, Q.
    CLINICAL ONCOLOGY, 2018, 30 (06) : E56 - E56
  • [49] IAEA RCA 6065: IMPROVING ACCESS TO STEREOTACTIC ABLATIVE BODY RADIOTHERAPY (SABR) FOR LUNG CANCER PATIENTS IN ASIA
    Hegi-Johnson, Fiona
    Siva, Shankar
    Foote, Matthew
    Tan, Daniel
    Kim, Mi-Sook
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S1130 - S1130
  • [50] Clinical outcomes of stereotactic ablative body radiotherapy (SABR) in medically inoperable early stage lung cancer patients
    Groves, Jonathan
    Yeo, Ryan
    Tsang, Yat
    Shah, Nihal
    Win, Thida
    EUROPEAN RESPIRATORY JOURNAL, 2021, 58
12345